Longevity: Economic Value in Medical Progress

As life expectancy rises, the disparity between lifespan and healthy years is growing. Bellevue Asset Management sees this imbalance as a critical growth driver in healthcare, providing investment opportunities. Their strategy focuses on innovations for early disease detection, slowing progression, and maintaining independence in old age. Between 2000 and 2019, life expectancy increased by 6.5 years, whereas healthy life expectancy only by 5.4 years. This gap results in chronic diseases, notably cardiometabolic and neurodegenerative conditions, fueling healthcare costs.

Investment in longevity targets prevention and early medical intervention, particularly through digital health technologies and minimally invasive treatments. Economic gains are seen in reduced healthcare costs and preserved independence. The Bellevue Healthcare ETF invests in strategies that measurably extend healthspan. With about 80% devoted to companies in direct longevity sectors, and 10-20% in related fields, the ETF capitalizes on this sustainable growth trend in healthcare.